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Abstract
Background: Anopheles stephensi mitochondrial malic enzyme (ME) emerged as having a relevant role in the
provision of pyruvate for the Krebs’ cycle because inhibition of this enzyme results in the complete abrogation of
oxygen uptake by mitochondria. Therefore, the identification of ME in mitochondria from immortalized A. stephensi
(ASE) cells and the investigation of the stereoselectivity of malate analogues are relevant in understanding the
physiological role of ME in cells of this important malaria parasite vector and its potential as a possible novel target
for insecticide development.
Methods: To characterize the mitochondrial ME from immortalized ASE cells (Mos. 43; ASE), mass spectrometry
analyses of trypsin fragments of ME, genomic sequence analysis and biochemical assays were performed to
identify the enzyme and evaluate its activity in terms of cofactor dependency and inhibitor preference.
Results: The encoding gene sequence and primary sequences of several peptides from mitochondrial ME were
found to be highly homologous to the mitochondrial ME from Anopheles gambiae (98%) and 59% homologous to
the mitochondrial NADP
+-dependent ME isoform from Homo sapiens. Measurements of ME activity in mosquito
mitochondria isolated from ASE cells showed that (i) Vmax with NAD
+ was 3-fold higher than that with NADP
+,( ii)
addition of Mg
2+ or Mn
2+ increased the Vmax by 9- to 21-fold, with Mn
2+ 2.3-fold more effective than Mg
2+,( iii)
succinate and fumarate increased the activity by 2- and 5-fold, respectively, at sub-saturating concentrations of
malate, (iv) among the analogs of L-malate tested as inhibitors of the NAD
+-dependent ME catalyzed reaction,
small (2- to 3-carbons) organic diacids carrying a 2-hydroxyl/keto group behaved as the most potent inhibitors of
ME activity (e.g., oxaloacetate, tartronic acid and oxalate).
Conclusions: The biochemical characterization of Anopheles stephensi ME is of critical relevance given its important
role in bioenergetics, suggesting that it is a suitable target for insecticide development.
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Background
Recently, several pathways for energy production have
been identified in mitochondria from Anopheles ste-
phensi [1], a well-studied Anopheles species in the inves-
tigation of malaria transmission [2]. The mitochondria-
dependent energy pathways mainly use proline, pyru-
vate, a-glycerophosphate, and acyl-carnitine derivatives
as suitable substrates. Proline is also the main substrate
for flight metabolism in the tsetse fly [3], the mosquito
Aedes aegypti [4] as well as other insects [5]. About 20%
of the glutamate produced by proline oxidation is in
turn oxidized by glutamate dehydrogenase [6], whereas
the remainder undergoes transamination by reaction
with pyruvate and the resulting alanine accumulates as
the proline is utilized. The 2-oxoglutarate formed by
transamination is further metabolized by the Krebs’
cycle. Originally pyruvate was thought to be produced
from oxaloacetate by an oxaloacetate decarboxylase [7],
but this enzyme was later localized in the cytoplasm
whereas proline oxidation and subsequent reactions all
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any medium, provided the original work is properly cited.take place in the mitochondria [6], consistent with pre-
vious studies [1]. Mitochondria of cultured cells [ASE
cell line (A. stephensi Mos. 43 cell line)] from A. ste-
phensi, as well as flight muscle mitochondria of a beetle
(Popillia japonica), which also have the ability to oxidize
proline at a high rate, have been shown to contain an
unusually active malic enzyme [8]. The latter species
utilizes NAD
+ preferentially as a coenzyme and presum-
ably produces pyruvate by the oxidative decarboxylation
of malate [8]. This mitochondrial enzyme in insects may
have a critical role in the replenishment of pyruvate for
either transamination or Krebs’ cycle.
Malic enzyme (ME; EC 1.1.1.39) catalyses the reversi-
ble oxidative decarboxylation of L-malate to pyruvate
and CO2 with the concomitant reduction of the cofac-
tor NAD
+ or NADP
+ [9-11]. The enzyme requires
divalent cations (Mg
2+,M n
2+, or others) in the cataly-
s i so ft h i sr e a c t i o n .M Ea c t i v i t yw a sf i r s ti s o l a t e df r o m
pigeon liver [12] and has since been found in most liv-
ing organisms, from bacteria to humans. Most MEs are
homotetramers, with monomers containing 550 amino
acids and having molecular weights of 60 kDa. The
amino acid sequences of MEs are highly conserved
across all studied organisms, but they lack recognizable
homology to other proteins, including other oxidative
decarboxylases. The wide distribution of ME activity in
nature and the high degree of sequence conservation
are consistent with the important biological functions
of these enzymes, such as photosynthesis in C4 plants
and even some C3 plants [13] and biosynthesis of fatty
acids and steroids in liver and adipose tissues in ani-
mals. In mammals, three isoforms of ME have been
identified–cytosolic NADP
+-dependent ME (ME-1;
[14]), mitochondrial NADP
+-dependent ME (ME-3;
[15]), and mitochondrial NAD(P)
+-dependent ME
(ME-2; [10]), which can use either NAD
+ and NADP
+
as a cofactor (dual specificity), but prefers NAD
+
under physiological conditions. In invertebrates, and in
particular in insects, unusually high activity of NAD
+-linked malic enzyme has been reported in flight mus-
cle mitochondria of the beetle Popillia japonica [8]
and from the tsetse fly and other insects [16].
Based on previous reports [1], ASE mitochondrial ME
emerged as having a relevant role in the provision of
pyruvate for the Krebs’ cycle because the chemical inhi-
bition of this enzyme resulted in the complete abroga-
tion of oxygen uptake by mitochondria. Therefore, the
identification of ME in ASE mitochondria and the inves-
tigation of the stereoselectivity of malate analogues are
relevant in understanding the physiological role of ME
in cells of this important malaria parasite vector and its
potential as a possible novel target for insecticide
development.
Methods
Chemicals
Organic acids were purchased from Sigma Chemical Co.
(St. Louis, USA). All reagents were of analytical grade.
Cell maintenance
The immortalized A. stephensi ASE cell line was grown
in modified Eagle’s minimal essential medium ("E5”)
supplemented with glucose, L-glutamine, vitamin solu-
tion, nonessential amino acids, penicillin and streptomy-
cin, and 5% heat-inactivated fetal bovine serum at 28°C
with 5% CO2 as described [1]. The population doubling
time of these cells is approximately 18-20 h. The cells
were split 1:10 into E5 medium and grown in 50 ml cul-
ture flasks until confluent. These flasks were used to
seed 500-ml culture flasks to prepare ~2 billion cells for
mitochondria preparation. Cells harvested for mitochon-
dria preparation were gently pipetted, resuspended in
the medium, and transferred to 50-ml tubes. Cells were
pelleted by centrifugation at 800 g for 5 min. The super-
natant was removed, and the cells were resuspended in
a small amount of medium by gentle pipetting and
transferred to a sterile holding tube on ice. This cycle
was repeated, with collection of the concentrated cells
into one tube, until all flasks were processed.
Isolation of mitochondria
Cells were centrifuged for 1 min at 500 g at 4°C and
mitochondria were isolated from pelleted cells as
described [1]. The pellet was weighed and MSHE buffer
w a sa d d e da tar a t i oo f3m lo fM S H Eb u f f e r( 2 2 0m M
mannitol, 70 mM sucrose, 0.5 mM EGTA, 0.1% fatty
acid-free bovine albumin, and 2 mM HEPES, pH 7.4)
per 1 g of cells. The cells were disrupted by gentle
homogenization, centrifuged at 600 g for 5 min at 4°C,
the pellet was discarded, and the supernatant was centri-
fuged at 10,300 g for 10 min at 4°C. The pellet, which is
rich in mitochondria, was resuspended in a small
volume of MSHE. Using this procedure the yield was
7.5 ± 0.5 μg mitochondrial protein/10
6 cells. Protein
concentration was determined by using the BCA Protein
Assay (Pierce).
Enzymatic assays
The ME enzymatic assay was performed using a method
outlined by [17] with the following modifications. Mos-
quito mitochondria were homogenized in MSHE con-
taining 2 mM mercaptoethanol. In a 1 ml cuvette, 2-μg/
ml antimycin, 1 mM L-malate, 0.3 mM NAD
+,5 0m M
HEPES (pH 7.8), and 3 mM of MnCl2 (unless indicated
otherwise) were added. The reaction was initiated with
the addition of 40 μg of mosquito mitochondrial lysate
protein. The change in absorbance was measured using
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utes (control). The ME specific activity was calculated
for each trace utilizing the extinction coefficient for
NADH at 340 nm (6.22 mM
-1 cm
-1). Each L-malate
analogue was added to the reaction mixture at the indi-
cated concentrations and the change in absorbance was
measured for another 3-5 minutes.
Mass spectrometry analysis, protein identification, and
confirmation of A. stephensi encoding sequence
LC-MS/MS analyses were performed at the Proteomics
Facility of the University of California Davis Genome
Center. Tandem mass spectra were extracted by Bio-
Works version 3.3. Charge state deconvolution and dei-
sotoping were not performed. All MS/MS samples were
analysed using X! Tandem [18,19]. X! Tandem was set
up to search the Ensemble A. gambiae protein database
(13,740 entries) assuming the digestion enzyme trypsin.
X! Tandem was searched with a fragment ion mass tol-
erance of 0.40 Da and a parent ion tolerance of 1.8 Da.
Iodoacetamide derivative of cysteine was specified in X!
Tandem as a fixed modification. Deamidation of Asn
and Gln, oxidation of Met and Trp, sulphone of Met,
Trp oxidation to formylkynurenin of Trp and acetylation
of the N-terminus were specified in X! Tandem as vari-
able modifications. Scaffold (version Scaffold-3_00_08)
was used to validate MS/MS based peptide and protein
identifications. Peptide identifications were accepted if
they could be established at greater than 90.0% probabil-
ity as specified by the Peptide Prophet algorithm [20].
Protein identifications were accepted if they could be
established at greater than 99.0% probability and con-
tained at least 2 identified peptides. Protein probabilities
were assigned by the Protein Prophet algorithm [21].
Proteins that contained similar peptides and could not
be differentiated based on MS/MS analysis alone were
grouped to satisfy the principles of parsimony.
To identify the full-length coding sequence for A. ste-
phensi ME, the A. gambiae ME amino acid sequence
(Q7QB64) was used as a query by Dr. Zhijian (Jake) Tu
(Virginia Tech) to identify homologous sequence in the
June 2010 unpublished draft of the A. stephensi assem-
b l yb yT B L A S T N( e - v a l u ec u t o f f1 e
-7). The region with
the best match plus 1-kb flanking sequences on either
side were retrieved.
Statistical analyses
The experiments were run in duplicate or triplicate and
repeated two times in independent experiments. Data
were expressed as mean ± SEM. The data were evalu-
ated by using the t-test (StatSimple v2.0.5; Nidus Tech-
nologies, Toronto, Canada) with p ≤ 0.05 considered as
statistically significant.
Results and discussion
Identification of the mitochondrial ME from A. stephensi
To characterize the ME in A. stephensi cells, Multidi-
mensional Protein Identification Technology (MudPIT)
was used. This technique involves digesting mosquito
proteins with trypsin and separating the resulting pep-
tides with two liquid column chromatography steps: the
first being a strong cationic exchange, and the second
being reversed-phase HPLC. As the peptides elute from
the second column, they are sprayed into a linear ion
trap mass spectrometer. The first MS scan assigned
each peptide a mass/charge ratio. The most intense pep-
tide signals are then fragmented in a second MS/MS
scan, which assigns each peptide a unique “fingerprint”
(Figure 1). The fingerprints are then analysed against
Figure 1 Mass spectrometry analyses of ASE ME. Mass spectrometry results from MudPIT analyses indicating the peptide sequences,
identification probability to A. gambiae Q7QB64, peptide modifications identified by spectrum (carboxymethylated or CM, methionine sulfoxide
or OX, and deaminated or DA), calculated and actual peptide masses, and peptide start and end amino acid from the above indicated A.
gambiae sequence.
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tein’s identity.
Six out of seven unique peptides had a ≥ 90% match
with one of two MEs reported for A. gambiae (Q7QB64;
Figure 1); only one of these peptides showed a peptide
identification probability of approximately 51%. These
peptides provided 26% protein coverage (148 amino
acids out of 572; Figure 2). Given the high homology of
these peptides to A. gambiae Q7QB64 (Figure 2), this
sequence was used to query the A. stephensi genome
assembly. This analysis retrieved the homologous A. ste-
phensi ME sequence (Additional file 1). The predicted
A. stephensi protein sequence (Additional file 1) revealed
a 98% homology (99% positives) with A. gambiae ME
(Q7QB64; Additional file 1).
BLAST query of the complete amino acid sequence of
A. stephensi ME to the non-redundant NCBI database
revealed high identity to MEs from mosquitoes (A. gam-
biae 96%, Anopheles darlingi 94%, Aedes aegypti 88%,
Culex pungens 87%), flies (Drosophila spp. 75%, Glossina
spp. 62%), ants (Harpegnathos spp. 74%; Camponotus
spp. 74%), lice (Pediculus spp. 73%), moth (Bombyx spp.
64%), and a nematode (Ascaris suum 54%). BLAST
query against the human database revealed a 59% iden-
tity to the human mitochondrial NADP
+-dependent ME
(or ME-3), followed by a 57% and a 55% identity to the
human cytosolic ME-1 and the human mitochondrial
ME-2, respectively. The lower homology of the A. stepe-
phensi ME with the human mitochondrial counterpart
was not due to the mitochondrial targeting sequence
because its removal from the human isoform and rea-
lignment of the mature protein with the mosquito pro-
tein did not change the identity (59%), similarity (75%)
or score (1742). Of note, the two human mitochondrial
ME isoforms share only 54% of their amino acids, which
is the same range of homology when comparing human
MEs with A. stephensi ME (this study) or from maize
chloroplasts (47%). By comparison the highly homolo-
gous A. gambiae ME (Q7QB64) is 59% identical to the
human ME-3, 57% to human ME-1, and 55% to human
Figure 2 Protein alignments of A. gambiae MEs. Sequence alignment of the two ME proteins from Anopheles gambiae (Q7PRY4 and Q7QB64).
Sequence alignments of the two ME proteins (sequences as reported in the SwissProt database; last visited on April 13, 2011). The alignments
were generated using CLUSTAL [55]. Boxed amino acids indicate the peptides identified by mass spectrometry from Figure 1.
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(Q7PRY4) has 60% identity to the human ME-1, 58% to
ME-3, and 53% to ME-2. As in A. gambiae,t w oM E s
have been identified for A. darlingi,i nw h i c ho n eo f
them (E3WUS4) is 62% identical to the human ME-1,
while the other ME (E3WW73) is 60% identical to the
human ME-3. Thus, for these mosquito species, no ME-
2 ortholog (mitochondrial and NAD
+-dependent) is
apparent. In agreement with these findings, only one
mitochondrial ME from A. stephensi was detected in the
performed MudPIT analyses and genome sequence ana-
lyses. However, a possible A. stephensi ME paralog with
approximately 60% identity to A. gambiae ME
(Q7QB64) was detected (Dr. Zhijian Tu, personal com-
munication). While this encoded protein is potentially
interesting, we have focused on the highly homologous
A. stephensi ME here.
With the primary sequence of the A. stephensi ME, a
high-quality prediction of the 3D structure and biologi-
cal function of the ME was performed by using a tem-
plate-based modelling platform [22,23]. The results of
this modelling (Additional file 2) revealed that the 3D
structure of A. stephensi ME (with a C-score of 1.985)
was closely related to that of Ascaris suum (1o0sA; TM
score 0.9645; RMSD 1.43, identity 0.53; coverage 99%;
Figure 3). This 3D model of A. stephensi ME was based
on templates from human ME-1 (2aw5B), human ME-2
(1pj3A and 1gz4A) and Ascaris suum (1llqA and 1o0sA;
Additional file 2). The modelling results also predicted
the binding site for various ligands (Additional file 2). In
particular, the predicted binding sites for Mn
2+,o x a l a t e
and NADP
+ resemble those in pig liver ME-1, whereas
those for tartronate, malate, fumarate and Mg resembled
t h o s ei nh u m a nM E - 2 .T h eb i n d i n gs i t ef o rt a r t r o n a t e
was also similar to that defined for Ascaris suum ME.
To gain insight in the activity of ME, enzymatic para-
meters were evaluated in mosquito mitochondria iso-
lated from ASE cells. The production of NAD(P)H was
followed in the presence of malate and NAD(P)
+.T h e
Km value for L-malate was calculated as a function of
total concentrations of the substrate and it was found to
be 0.12 mM at the pH of 7.8 (Table 1). A low activity
was obtained in the absence of cofactors (Mg
2+ or Mn
2
+), but the addition of either metal increased signifi-
cantly the maximum activity (9 to 21-fold); however,
Mn
2+ was a better cofactor than Mg
2+ (2.3-fold of Mg
2+
alone; Table 1). The specific activity of the ASE ME
enzyme was significantly higher than that of the other
two human mitochondrial isoforms: the specific activ-
ities of the human mitochondrial NADP
+-ME and NAD
+-ME have been reported as 12 U/mg protein (1 U or
unit = 1 μmol/min) and 35 U/mg protein, respectively,
whereas the activity of the human cytosolic NADP
+-ME
is 40 to 55 U/mg [15]. ASE ME could utilize either
NAD
+ or NADP
+; however, Vmax with NAD
+ was 3-
times higher than that with NADP
+ (Table 1), consistent
with the predictions made from the protein similarity
search (vide supra) and structure (vide infra).
It has been shown that the presence of basic residues
at positions 67 and 91 of human ME-2 are apparently
critical for fumarate-dependent activation [24] (Figure
4A, residues marked with asterisks). All three human
isoforms contain Arg at the equivalent positions [24]
but only ME-2 is activated by fumarate. Thus, other fac-
tors may contribute to this activation [24]. The mutation
o ft h ea m i n oa c i dr e s i d u eA s p - 1 0 2h a das i g n i f i c a n t
effect on the fumarate-mediated activation of human
ME-2 [25]. At this position, the human ME-1 and ME-3
isoforms have a Ser residue and they do not show any
increase in activity with fumarate. The mosquito ME
has a Glu at this position, and the Ascaris suum ME has
an Asp, suggesting that these isoforms, like the human
ME-2, may be activated by fumarate by conserving the
negative charge at this position. On the other hand, in
the mosquito ME, Leu occupies the equivalent position
of Arg-67 (all human isoforms and the nematode ME
have an Arg in this position), suggesting that mosquito
ME should not be activated by fumarate. In addition to
Arg-67, it has been reported that in the nematode mito-
chondrial ME, the residues that are involved in the
binding of fumarate are Ala-78, Leu-81 and Leu-105
(Figure 4A, rows indicated with arrows), which in A. ste-
phensi ME are occupied by Ile, Leu and Leu in agree-
ment with the nematode isoform, which is activated by
fumarate. In agreement with this last prediction, succi-
nate and fumarate increased the activity by 2- to 5-fold,
respectively, at sub-saturating concentrations of malate
Figure 3 Three-dimensional structures of A. stephensi and
Ascaris suum MEs. The 3D structure of A. stephensi ME (A) was
obtained through modelling from the primary sequence from
Additional file 1 and the use of the modeling software I-TASSER
(results shown in Additional file 2). The 3D structure of Ascaris suum
ME was obtained from the protein database and corresponds to the
accession number 1o0sA. Both pdb files were visualized using
PyMol 1.4.1 [56].
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shown). Other amino acids, such as Pro, had a moderate
effect on enzyme activity up to concentrations of 10
mM (1.4-fold). Surprisingly, Glu was found to be a
potent activator increasing ASE ME activity by 4-fold at
saturating concentrations of malate (Figure 5B).
O n ev e r yh i g h l yc o n s e r v e dr e g i o nd e f i n e da sap a r to fa
malate-binding domain is shown in Figure 4B. This
region has been identified on the basis of inhibition
experiments carried out on NADP
+-dependent ME with
the competitive inhibitor bromopyruvate [15]. Indeed, a
highly conserved Cys (Figure 4B, asterisk) and the pre-
ceding sequence VYTPTVG (Figure 4B, bar) are present
in this domain in human, nematode, plant and A. gam-
biae and A. stephensi mosquito isoforms (Figure 4B),
suggesting that the same type of binding occurs in the
mosquito isoforms. However, recently the role of this
Cys has been challenged based on crystallography data
[24]. This study indicated that this residue is about 13 Å
away from the substrate analog oxalate suggesting that
the inhibition of substrate binding upon chemical modi-
fication of this Cys is an indirect effect.
The proposed ADP binding beta-alpha-beta fold is
shown which contains a characteristic arrangement of
Gly residues and nonpolar and hydrophilic amino acids
at specific positions (Figure 4C, boxed amino acids;
[26]). A highly conserved Cys residue (or the highly
similar Ser in plant NADP ME-2; Figure 4C, asterisk)
o b s e r v e di nt h i sr e g i o ni sp r e s e n ti na l lN A D P
+-depen-
d e n tm a l i ce n z y m e s[ 2 7 ]b u ti sa b s e n tf r o mt h eN A D
+-dependent malic enzymes (human ME-2, nematode
and mosquito isoforms). Therefore the presence or
absence of this Cys or Ser residue in this binding fold
apparently distinguishes the preference for NADP
+ over
NAD
+ as suggested before by others [28].
The fingerprint region of NAD(P)
+-binding sites is
characterized by a Gly-rich sequence (Gly-X-Gly-X-X-
Gly; Figure 4D, boxed amino acids), which is the phos-
phate binding consensus [29,30]. The first Gly allows
the tight turn of the main chain, the second allows a
close contact to the diphosphate of NAD(P)
+,a n dt h e
third is important for the close packing of the secondary
structure [29,31]. This third Gly is replaced by larger
amino acids (Ala or Ser) in enzymes that utilize NADP
+
(e.g., glutathione reductase, thioredoxin reductase)
because it is believed that disrupting the close packing
of the secondary structure allows the structure to
accommodate the phosphate moiety of NADP
+ [29].
Furthermore, protein engineering of glutathione reduc-
tase, in which Ala-179 was replaced by a Gly residue at
an equivalent position in this enzyme, both in single as
well as in multiple substitutions, caused NAD
+ binding
preference over that of NADP
+ [32]. However, this rea-
soning does not seem to apply to all MEs listed in Fig-
ure 4D (position marked with asterisk). In particular, all
human MEs have a third Gly regardless of the cofactor
preference, indicating that other factors are contributing
to the cofactor preference. In support of this statement,
Gly residues in the boxed segments shown in Figures
4C &4D when replaced by Val residues rendered abor-
tive mutants of maize C4 NADP
+-ME [31]. This is con-
sistent with the three-dimensional model obtained for
the maize C4 NADP
+-ME showing that residues at both
sites are part of the NADP
+-binding site justifying the
high degree of conservation among all NAD(P)
+-ME
[31].
It has been suggested that two Ala residues spaced by
three amino acids (Gly-X-Gly-X-X-Ala-X-X-X-Ala; Fig-
ure 4D indicated with a bar) are more characteristic for
NADP
+-binding domains relative to NAD
+-binding
domains, whereas Gly residues were more consistently
identified in NAD
+-dependent enzymes [31,32]. How-
ever, all human ME isoforms, nematode mitochondrial
ME and A. stephensi ME have an Ala-X-X-X-Ala seg-
ment, regardless of whether they use NADP
+ or NAD
+.
Other residues may also affect binding specificity of
NAD(P)
+ in MEs. It has been noted that all NADP
+-
dependent ME isoforms have a conserved Lys at Gln-362
in human ME-2 (Figure 4E, asterisk; [33]), whereas dual
specificity MEs have heterogeneous residues at this posi-
tion [34] (Figure 4E, asterisk). This observation, combined
with mutational and modelling studies using pigeon ME-1,
led to the supposition that in NADP
+-dependent MEs,
NADP
+ specificity is conferred by Lys at this position.
Mitochondrial NAD
+-MEs of Ascaris and other species
may have no need to exhibit strict specificity for NAD
+
due to the high concentration of NAD
+ relative to NADP
+
within mitochondria, and thus the residue at the
Table 1 Effect of cofactors on Vmax of ME activity
Addition Km for malate
(mM)
Vmax
nmol × (min × mg protein)
-1
p-value to controls
None - 3 ± 1 -
MgCl2 (3 mM) - 24 ± 2 0.02
MnCl2 (3 mM) 0.12 56 ± 3 (20 2) 0.01
All kinetic parameters were obtained with NAD
+ except the Vmax obtained with NADP
+ (value in parentheses). The Vmax values were expressed as mean ± SEM.
All other experimental details are described in the Methods.
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Page 6 of 12Figure 4 Analyses of protein sequence alignments of various MEs. Sequence alignments of maize (NADP
+-ME-2, chloroplastic NADP
+-ME,
and NADP
+-ME-4), human (ME-1, ME-2, and ME-3), nematode (NAD
+-ME-2), bacterial (NAD
+-ME) and A. stephensi ME (mosquito ME). The amino
acid sequences of the ME isoforms were analyzed by BLAST against the SwissProt database, and the alignments were generated using CLUSTAL
[55]. The amino acid residues highlighted in grey share high homology whereas those in bold are identical. Key amino acids discussed in the
text are shown with asterisks, arrows or bars (see text for full description). (A) Sites involved in fumarate activation; (B) Malate binding site; (C)
ADP binding site; (D) NAD(P)
+ binding domain and sites associated with NAD
+ versus NADP
+ preference; (E) Other sites also associated with
NAD
+ versus NADP
+ preference. For complete protein nomenclature see Additional file 3.
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strained to Lys. Indeed, in mosquito ME (this study),
nematode ME, human ME-2 and bacteria ME, this
sequence position corresponds to a Lys, His, Gln and Glu,
respectively (Figure 4E, asterisk). Recent data clearly indi-
cate that the Gln-362-Lys mutant of human ME-2 is a
non-allosteric, non-cooperative and NADP
+-specific
enzyme, as is ME-1 [33]. Additionally, Gln-362-Lys is
more sensitive to ATP, and the inhibition constant is
smaller than that of wild-type [33]. Sequence alignments
of the nucleotide-binding region among MEs have
revealed that, in addition to Gln-362, Lys-346 is conserved
among the NAD
+-dependent malic enzymes (human ME-
2; Figure 4E arrow), but in NADP
+-dependent MEs
(maize, human), this Lys is replaced by Ser (Figure 4E
arrow). In the case of A. stephensi ME, this residue is
replaced by Ile, as it is in the case of the nematode ME.
Thus, in those isoforms with NADP
+-only specificity, a
Lys in position 362 (Figure 4E asterisk) and a Ser in 346
(Figure 4E arrow) are apparently necessary.
ATP acts as an active-site inhibitor of mitochondrial
ME-2 following a competitive mechanism for NAD
+ and
malate with Ki values from 80 to 430 μM [24,35].
According to Hsieh et al [36], the presence of Lys-346
in mammalian ME-2 is critical for ATP inhibition (Fig-
ure 4E, arrow) because site-directed mutagenesis of this
residue to Ala or Ser diminishes ATP-mediated inhibi-
tion. This result suggested that the positive charge is
critical for ATP binding. As indicated above, in the
human ME-1 and ME-3 as well as the plant MEs, in iso-
forms that are not inhibited by ATP, the equivalent
positions for Lys-346 are occupied by Ser. In the mito-
chondrial nematode and mosquito MEs, Ile residues are
present in these positions, thus no significant effect of
ATP would be expected as it has been shown for the
Ascaris ME [37,38]. In agreement with this prediction,
kinetic results showed that ATP was not an inhibitor
with respect to NAD
+ or L-malate in A. stephensi mito-
chondrial ME at the concentrations tested (20 to 1,000
μM; data not shown). The Arg-197, Arg-542 and Arg-
556 residues in human ME-2 appear to be involved in
the binding of ATP at the exosite [24]. These residues
differ from those in human ME-3 or mosquito ME
(human ME-3 = Gln, Tyr and Leu and mosquito ME =
Figure 5 Effect of L-malate analogues on ME activity. A. Chemical structure of L-malate and structural analogues. B. Effect of L-malate
analogues on ASE mitochondrial ME enzymatic activity. The activity of ME was evaluated in the absence and presence of the following
inhibitors/compounds at saturating concentrations of all other cofactors and substrates except for succinate and fumarate which are shown at
subsaturating concentrations of malate (0.5 mM): 1 mM oxaloacetate; 5 mM tartronic acid; 1 mM oxalate; 2.5 mM alpha-ketobutyrate; 2.5 mM
beta-hydroxybutyrate; 2.5 mM alpha-hydroxybutyrate; 2.5 mM acetoacetate; 2.5 mM malonate; 10 mM pyruvate; 10 mM proline; 10 mM
succinate; 10 mM glutamate; and 5 mM fumarate.
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Page 8 of 12Gln, Thr and His), suggesting that this binding is not
operational in these isoforms.
Inhibitors of the A. stephensi mitochondrial ME
Several analogues of L-malate were tested as inhibitors
of the NAD
+-dependent ME catalyzed reaction (Figure
5A). Oxalate, oxaloacetate, tartronate and alpha-ketobu-
tyrate were found to be inhibitors of the ME-catalyzed
reaction, through a competitive mechanism with respect
to the substrate (malate) concentration. Their Ki values
ranged from 0.1 (oxaloacetate and oxalate) to 0.6 μM
(tartronate; Table 2). Alpha-hydroxybutyrate and the
ketone bodies beta-hydroxybutyrate and acetoacetate did
not exhibit any effect on the ME activity. The same out-
come was obtained with either malonate or pyruvate
(Figure 5B).
The catalysis by ME generally proceeds in two steps,
namely the dehydrogenation of malate to produce oxa-
loacetate, and then the decarboxylation to produce pyru-
vate. In a proposed enzymatic catalysis based on
structural data the crystallography data, the latter step is
believed to occur through the formation of a keto-enol
intermediate structurally similar to oxalate [39]. The
strongest ME inhibitors for which Ki were evaluated (i.
e., oxalate, oxaloacetate, and tartronate) are consistent
with this mechanism, for these compounds are either
intermediates (i.e., oxaloacetate, oxalate) or structurally
similar intermediates (tartronate or ketomalonate) that
fit the tight active site of the enzyme [39]. Besides the
role of size, these inhibitors are diacids. Thus, the pre-
sence of an extra carboxyl group appears to be neces-
sary for binding the substrate (or inhibitor) to the
enzyme, probably through an induced dipolar type bond
with the side chains of Gln and Asn, as suggested by
others [40]. In support of this rationale, the presence of
the extra carboxylate in malate and oxaloacetate com-
pared to alpha-hydroxybutyrate and alpha-ketobutyrate,
respectively, yielded stronger inhibition of ME (Figure
5).
Within the diacids, the presence of a keto group in
position 2 seemed to be an important factor in control-
ling the inhibitory effect of the compounds studied, for
lack of this moiety in, for example, succinate or fuma-
rate, resulted in a loss of the inhibitory effect. The
change of the 2-keto group of the alpha-ketobutyric acid
to 2-hydroxy (alpha-hydroxybutyrate) or the transfer to
the 3-hydroxy (beta-hydroxybutyrate) resulted in negligi-
ble effect on the ME activity (Figure 3B). Thus, the keto
group in position 2 seems essential for effective inhibi-
tion of ME, possibly by favoring π-π interactions with
the nicotinamide ring of NAD
+ and/or hydrogen bond-
ing with the side chain amide of Asn and the 2’-hydro-
xyl of the nicotinamide ribose [39]. These results
s u g g e s tt h a tt h ee x t e n to fi n hibition was dependent on
the size of the analogues (2 to 4-carbons), the presence
of two carboxyl groups along with a 2-hydroxyl or 2-
keto moiety important for binding of the substrate ana-
l o g u et ot h ee n z y m e .I nas t u d yp e r f o r m e dw i t ht h e
enzyme from Flaveria trinervia, the presence of a group
with a low pK value (6 to 6.6), probably an H residue,
was responsible for the binding of the 2-hydroxyl of
malate and transfer of the hydride to form the inter-
mediate oxaloacetate [41]. These results suggest that the
extent of inhibition was dependent on the size of the
analogues (2 to 3-carbons), the presence of two carboxyl
groups along with a 2-hydroxyl or 2-keto moiety impor-
tant for binding of the substrate analogue to the
enzyme.
The ME-3 gene is conserved in human, chimpanzee,
dog, cow, mouse, rat, a variety of flies and mosquito
species, Caenorhabditis elegans, Arabidopsis thaliana,
and rice. The mammalian ME-3 isoform has a strong
tissue-specific expression,m o s t l yi no r g a n sw i t hal o w
division rate (e.g., heart, skeletal muscle and brain; [15])
or with an involvement in steroid hormone biosynthesis
(ovary and testes). High activity of ME-3 has also been
reported in muscle of crustaceans and fish [42]. It has
been previously reported that the immortalized cells
from A. stephensi, from which the ME activity in this
study was evaluated, resembled skeletal muscle cells [1].
Thus, the finding of a high activity of this mitochondrial
enzyme is consistent with this previous study. Given
that the reverse reaction (i.e., the carboxylation of pyru-
vate) was 12-times slower than the forward reaction
(not shown), the role for ME-3 in the anaplerotic reac-
tion (pyruvate to malate) of the Krebs’ cycle is expected
to be negligible.
A previous report indicated that addition of tartronic
acid completely inhibited the oxygen consumption of
Pro-supplemented phosphorylating mitochondria [1].
This suggests a critical role for ME in a pathway to
Table 2 Inhibition constants of various malate analogues
Compound Ki (μM)
Oxaloacetate 0.12
Oxalate 0.15
Tartronate 0.61
Alpha-ketobutyrate n.d.
Inhibition studies were performed by varying the concentrations of L-malate
from 0.1 mM (subsaturating) to up to 1 mM (saturating) while the analogue
(chosen based on its inhibitory activity from Figure 3B) was held at several
fixed concentrations around its inhibition constant. Concentrations of the
other components in the assay mixture were held at saturation. Reciprocal
velocities were plotted as a function of reciprocal substrate concentrations
and all plots were linear in the range of substrate concentrations assayed (0.1-
0.5 mM). The lines were calculated from the fits of the experimentally
determined values to the appropriate kinetic parameters. Abbreviations: n.d,
not determined.
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Page 9 of 12provide NADH to the electron transport chain. The ME
will then be activated with glutamate, succinate or
fumarate as in the case when Pro or other suitable sub-
strate becomes available. The physiological function of
the inhibition by oxalate is not clear given the limiting
amount of this substrate in mitochondria. If NADH
levels are high and citrate concentration rises when
switching from high to low work, this would result in
an inhibition of citrate synthase and increases in oxalo-
cetate, which in turn would inhibit ME, and reduce the
supply of pyruvate and acetylCoA. An interesting feature
of this isoform is that the optimum pH was 7.8, which is
probably close to the physiological intramitochondrial
pH value under phosphorylating conditions [43].
It is likely that a secondary role of this enzyme in
mosquito mitochondria, based on the preferential use of
NAD
+ over NADP
+,i st op r o v i d eN A D P Hf o rt h e
detoxification of reactive oxygen radicals generated in
mitochondria during respiration. Glutathione reductase
activity requires NADPH to recycle oxidized glutathione
for the glutathione peroxidase system [44], and mito-
chondrial NAD
+-ME might contribute to the generation
of reducing equivalents.
Conclusions
The critical role of ME in the bioenergetics of mosqui-
toes along with the deeper understanding of its bio-
chemistry and chemical requirements for inhibition,
suggests that this enzyme could became a suitable target
for insecticide development. In this regard, structural
analogues of L-malate (especially C2 or C3 organic dia-
cids with a 2-hydroxyl or 2-keto group) behaved as the
most potent inhibitors of ME activity (e.g., oxaloacetate,
tartronic acid and oxalate).
Enzymes significantly associated with insecticide resis-
tance include esterases and cytochrome P450s involved
in the oxidative catabolism of insecticides [45-47]. Mito-
chondrial Complex I inhibitors seem to circumvent the
aforementioned resistance [5,48,49]. However, recent
studies of pyrethroid-resistant A. gambiae demonstrated
that exposure to permethrin induced strong upregula-
tion of genes that encode subunits of Complex I [50]
whereas the presence of MAP kinase Pmk1 and PKA
conferred resistance to Schizosaccharomyces pombe to
rotenone, a potent Complex I inhibitor [51]. In addition,
whereas most cases of insecticide resistance were usually
associated with mutations in the nuclear genome, a role
for maternally-inherited mtDNA has emerged as a pos-
sible mediator of resistance to Complex I inhibitors and
insecticides [47,52]. These observations suggest that
Complex I-associated resistance may already occur in
natural populations. Thus, this possibility should be
considered when resistance to current insecticides and
development of novel insecticides are evaluated. While
direct studies of insecticide resistance are beyond the
scope of the present study, it is important to bear in
mind that inhibition of multiple mitochondrial targets
(e.g., Complex I and ME) might result in synergistic
effects or in attenuation of the development of cross-
resistance as already observed when multiple, unrelated
targets for insecticides are tested [53,54].
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